PA
VLOS

PharVision Advisers’s Velos Acquisition I Corp VLOS Stock Holding History

PharVision Advisers’s Portfolio VLOS Stock Details VLOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,238
Closed -$247K – 680
2025
Q4 		$247K Buy
+23,238
New +$247K 0.13% 400

Other funds holding VLOS

MC
Meteora Capital Boca Raton, Florida $1.21B AUM 13.69% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
JG
Jain Global New York $25.4B AUM 45.67% 1-Year Est. Return
AIMCA
Alberta Investment Management Corp (AIMCo) Edmonton, Alberta, Canada $17.9B AUM 27.56% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CA
Crossingbridge Advisors Pleasantville, New York $567M AUM 0.34% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SC
Shay Capital New York $1.56B AUM 46.17% 1-Year Est. Return

PharVision Advisers's VLOS Position: Q1 2026 in Review

PharVision Advisers sold out of Velos Acquisition I Corp (VLOS) in Q1 2026, closing a stake of 23,238 shares — an estimated $247K sold.

PharVision Advisers first reported a position in VLOS in Q4 2025 and held it in 1 quarter. The position peaked at $247K in Q4 2025. 49 funds tracked by Wall St. Rank hold VLOS as of Q1 2026.

  • PharVision Advisers reported no remaining Velos Acquisition I Corp position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 23,238 Velos Acquisition I Corp shares in Q1 2026, an estimated $247K.
  • PharVision Advisers first reported a position in Velos Acquisition I Corp in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Velos Acquisition I Corp position peaked at $247K in Q4 2025.
  • 49 funds tracked by Wall St. Rank held Velos Acquisition I Corp as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.